Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.

Fernandez, Regina; Paz, Liliana I; Rosato, Roberto R; Rosato, Adriana E

Fernandez, Regina; Paz, Liliana I; Rosato, Roberto R; Rosato, Adriana E.

Afiliación

Fernandez R; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, USA.
Paz LI; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, USA.
Rosato RR; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, USA.
Rosato AE; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, USA Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA aerosato@houstonmethodist.org.

Antimicrob Agents Chemother ; 58(10): 5736-46, 2014 Oct.

Article en En | MEDLINE | ID: mdl-25022592

Asunto(s)

Antibacterianos/farmacología; Cefalosporinas/farmacología; Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos; Staphylococcus aureus Resistente a Meticilina/genética; Pruebas de Sensibilidad Microbiana; Mutación; Resistencia betalactámica/genética; beta-Lactamas/farmacología; Ceftarolina

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cefalosporinas / Staphylococcus aureus Resistente a Meticilina / Antibacterianos Tipo de estudio: Risk_factors_studies Idioma: En Revista: Antimicrob Agents Chemother Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google